insights_auto
Istiqbol: 50.0% optimistik·6.2% pessimistik
Tahlilga kirishchevron_right
INCY:NASDAQ
Incyte
124,82 US$
arrow_upward
+0,75%(+0,93) 1K
124,82 US$
0,00% (0,00)
bedtimeYopilgandan keyin
Savdolar yopilgan: 28-sen, 16:00:01 (GMT-4) · USD
search
Barcha belgilar
1K
5K
1O
6O
YBB
1Y
5Y
MAKS
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoINCY tikeri uchun statistika yaratilmoqda...
Ochish
123,32 US$
Yuqori
126,14 US$
Past
122,53 US$
Bozor kapitali
25,30 mlrd
Oʻrtacha hajm
1,40 mln
Hajmi
0,00
P/E koeffitsiyenti
15,91
52 haftalik eng yuqori
132,58 US$
52 haftalik eng past
82,52 US$
Aksiya boʻyicha daromad
7,85 US$
Beta
0,77
Muomaladagi aksiyalar
202,70 mln
Xodimlar soni
3 ming
Ochish
123,32 US$
Yuqori
126,14 US$
Past
122,53 US$
Bozor kapitali
25,30 mlrd
Oʻrtacha hajm
1,40 mln
Hajmi
0,00
P/E koeffitsiyenti
15,91
52 haftalik eng yuqori
132,58 US$
52 haftalik eng past
82,52 US$
Aksiya boʻyicha daromad
7,85 US$
Beta
0,77
Muomaladagi aksiyalar
202,70 mln
Xodimlar soni
3 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Simply Wall Street
·
1 soat oldin
Incyte (INCY), What Is Behind The Fresh Attention?
GuruFocus
·
10 soat oldin
INCY Maintained by JP Morgan -- Price Target Raised to $123.00
AD HOC NEWS
·
11 soat oldin
Incyte stock at USD 124.31 on September 28, 2026
Benzinga
·
12 soat oldin
FDA Expands Approval Of Eli Lilly's Olumiant For Adolescents with Autoimmune Hair Loss
Profil
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
Incyte haqida
CEO-
Xodimlar soni2,84 ming
Asos solingan2002
Bosh ofislarWilmington, Delaver, Amerika Qo‘shma Shtatlari
Sektor-
Veb-saytincyte.com